ConductScience.org, home

Trial · NCT05524727

Registered outcomes16

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange of Montreal Cognitive Assessment Scoreweek 0, week 12 and week 24Widely used screening tool and cognitive outcome in neurological patients including stroke
SecondaryChange of Stroke Impact Scale 3.0 Scoreweek 0, week 12 and week 24Stroke-specific measurement tool assessing patient-reported health-related quality of life
SecondaryChange of Simple Reaction Test Parametersweek 0, week 12 and week 24Widely used reliable and valid neuropsychological test assessing alertness
SecondaryChange of Trail Making Test A & B Parametersweek 0, week 12 and week 24Widely used reliable and valid neuropsychological test assessing processing speed and executive functions
SecondaryChange of Stroop Interference Test Parametersweek 0, week 12 and week 24Widely used reliable and valid neuropsychological test assessing the ability to inhibit the reaction to a more dominant stimulus in favour of the inquired reaction to a less dominant stimulus
SecondaryChange of N-back test Parametersweek 0, week 12 and week 24Widely used reliable and valid neuropsychological test assessing working memory and related cognitive functions
SecondaryChange of Mental Rotation Test Parametersweek 0, week 12 and week 24Measures the ability to mentally rotate abstract objects
SecondaryChange in Single- and cognitive Dual-Task Timed Up and Go Test Parameters and motor/cognitive dual task costsweek 0, week 12 and week 24Widely used, reliable and valid test of mobility and dual-task ability in various populations including stroke.
SecondaryChange of 10 meter walk test Gait Parametersweek 0, week 12 and week 24Widely used test to assess gait speed and spatiotemporal gait parameters.
SecondaryChange of Outdoor Gait Parametersweek 0, week 12 and week 24Assesses walking endurance and spatiotemporal gait parameters under daily-life conditions.
OtherCompliance Rateweek 12attended sessions / offered sessions
OtherAdherence Rateweek 12attended training time / offered training time
OtherPerceived Motor-Cognitive Task Difficultytwice per week, week 0-12visual analogue scale after each training session, based on cognitive load theory, scale from 1-9, where 9 symbolizes most difficult
OtherPerceived Performancetwice per week, week 0-12visual analogue scale after each training session, performance item of the National Aeronautics and Space Administration - Task Load Index, scale from 0 to 20, where 20 symbolizes highest performance
OtherDose and Content of Usual Careonce per week, week 0-24according to weekly questionnaire, based on TIDIeR checklist
OtherAmount and Intensity of General Physical and Cognitive Activityonce per week, week 0-24according to weekly questionnaire, based on TIDIeR checklist

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05524727/registered